Φορτώνει......
Deferoxamine Mesylate in patients with intracerebral haemorrhage: a Multi-Center, Randomised, Double-Blind, Placebo-Controlled, Phase II Trial
BACKGROUND: Iron, from hemolyzed blood, is implicated in secondary injury after intracerebral haemorrhage (ICH). We aimed to evaluate the safety of the iron chelator, Deferoxamine Mesylate (DFO), and whether it merits investigation in a Phase-III study to definitively assess its effectiveness in imp...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Lancet Neurol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494117/ https://ncbi.nlm.nih.gov/pubmed/30898550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(19)30069-9 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|